IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease

International Immunology

Volumn 23, Issue 11, 2011, Pages 679-691

  Bai, Xiyuan ^a,b,c   Ovrutsky, Alida R ^a,b,c   Kartalija, Marinka ^a,c   Chmura, Kathryn ^b   Kamali, Amanda ^d   Honda, Jennifer R ^c,d   Oberley deegan, Rebecca E ^b   Dinarello, Charles A ^c   Crapo, James D ^b   Chang, Ling Yi ^b   Chan, Edward D ^a,b,c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Immunohistochemistry; Non tuberculous mycobacteria

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 32; INTERLEUKIN 32GAMMA; UNCLASSIFIED DRUG;

AGED; APOPTOSIS; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIAL GROWTH; BASEMENT MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE SILENCING; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG GRANULOMA; LUNG INFECTION; MALE; MONOCYTE; MORPHOMETRICS; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM;

AGED; CASE-CONTROL STUDIES; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKINS; MACROPHAGES; MACROPHAGES, ALVEOLAR; MIDDLE AGED; MONOCYTES; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; NF-KAPPA B; RESPIRATORY SYSTEM; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES;

EID: 80055120218     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr075     Document Type: Article

References (73)

1. Griffith, D. E., Aksamit, T., Brown-Elliott, B. A. et al. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175:367.
2. Kasperbauer, S. H. and Daley, C. L. 2008. Diagnosis and treatment of infections due to Mycobacterium avium complex. Semin. Respir. Crit. Care Med. 29:569.
3. Prevots,D. R., Shaw, P. A., Strickland, D. et al. 2010. Nontuberculous mycobacterial lung disease prevalence at four integrated healthcare delivery systems. Am. J. Respir. Crit. Care Med. 182:970.
4. Taiwo, B. and Glassroth, J. 2004. Nontuberculous mycobacterial lung diseases. Infect. Dis. Clin. North Am. 24:769.
5. Marras, T. K., Chedore, P., Ying, A. M. and Jamieson, F. 2007. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax 62:661.
6. Iseman, M. D. and Marras, T. K. 2008. The importance of nontuberculous mycobacterial lung disease. Am. J. Respir. Crit. Care Med. 178:999.
7. Bodle, E. E., Cunningham, J. A., Della-Latta, P., Schluger, N. W. and Saiman, L. 2008. Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg. Infect. Dis. 14:390.
8. Griffith, D. E. and Stout, J. E. 2010. It is better to light a candle. than to repeat the opinions of experts. Am. J. Respir. Crit. Care Med. 182:865.
9. Winthrop, K. L., McNelley, E., Kendall, B. et al. 2010. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am. J. Respir. Crit. Care Med. 182:977.
10. Lai, C. C., Tan, C. K., Chou, C. H. et al. 2010. Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008. Emerg. Infect. Dis. 16:294.
11. Khan, K., Wang, J. and Marras, T. K. 2007. Nontuberculous mycobacterial sensitzation in the United States: national trends over three decades. Am. J. Respir. Crit. Care Med. 176:306.
12. Marras, T. K. and Daley, C. L. 2002. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin. Chest Med. 23:553.
13. Daley, C. L. and Griffith, D. E. 2010. Pulmonary non-tuberculous mycobacterial infections. Int. J. Tuberc. Lung Dis. 14:665.
14. Frehel, C., de Chastellier, C., Lang, T. and Rastogi, N. 1986. Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium. Infect. Immun. 52:252.
15. Kim, R. D., Greenberg, D. E., Ehrmantraut, M. E. et al. 2008. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am. J. Respir. Crit. Care Med. 178:1066.
16. Kwon, Y. S., Kim, E. J., Lee, S.-H. et al. 2007. Decreased cytokine production in patients with nontuberculous mycobacterial lung disease. Lung 185:337.
17. Safdar, A., Atrmstrong, D. and Murray, H. W. 2003. A novel defect in interferon-c secretion in patients with refractory nontuberculous pulmonary mycobacteriosis. Ann. Intern. Med. 138:521.
18. Safdar, A.,White, D. A., Stover, D., Armstrong, D. and Murray, H.W. 2002. Profound interferon gamma deficiency in patients with chronic pulmonary nontuberculous mycobacteriosis. Am. J. Med. 113:756.
19. Vankayalapati, R., Wizel, B., Samten, B. et al. 2001. Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J. Infect. Dis. 183:478-484.
20. Ma, X., Reich, R. A., Wright, J. A. et al. 2003. Association between interleukin-8 gene alleles and human susceptibility to tuberculosis disease. J. Infect. Dis. 188:349.
21. Khader, S. A. and Cooper, A. M. 2008. IL-23 and IL-17 in tuberculosis. Cytokine 41:79.
22. Khader, S. A., Bell, G. K., Pearl, J. E. et al. 2007. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369.
23. Cooper, A. M. and Khader, S. A. 2008. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 226:191.
24. Torrado, E. and Cooper, A. M. 2010. IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev. 21:455.
25. Bai, X., Kim, S., Azam, T. et al. 2010. IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages. J. Immunol. 184:3830.
26. Netea, M. G., Azam, T., Lewis, E. C. et al. 2006. Mycobacterium tuberculosis induces interleuckin-32 production through a caspase-1/IL-18/interferon-gamma-dependent mechanism. PLoS Med. 3:e277.
27. Kim, S. H., Han, S. Y., Azam, T., Yoon, D. Y. and Dinarello, C. A. 2005. Interleukin-32: a cytokine and inducer of TNFa.. Immunity 22:131-142.
28. Shoda, H. K., Fujio, Y., Yamaguchi, A. et al. 2006. Interactions between IL-32 and tumur necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res. Ther. 8:R166.
29. Hong, J., Bae, S., Kang, Y. et al. 2010. Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFalpha and IL-1beta. Cytokine 49:171.
30. Heinhuis, B., Koenders, M. I., van Riel, P. L. et al. 2010. Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade. Ann. Rheum Dis. 70:660-667.
31. Denis, M. and Ghadirian, E. 1994. Interleukin-1 is involved in mouse resistance to Mycobacterium avium. Infect. Immun. 62:457.
32. Bermudez, L. E., Wu, M. and Young, L. 1995. Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium. Infect. Immun. 63:4099.
33. Fieschi, C., Dupuis, S., Picard, C. and Casanova, J. L. 2003. Human interleukin-12-interferon-c axis in protective immunity to mycobacteria. In Kotb, M. and Calandra, T., eds, Cytokines and Chemokines in Infectious Diseases Handbook, p. 151. Humana Press, Totowa, NJ.
34. Petrofsky, M. and Bermudez, L. E. 1999. Neutrophils from Mycobacterium avium-infected mice produce TNF-alpha, IL-12, and IL-1 beta and have a putative role in early host response. Clin. Immunol. 91:354.
35. Schneider, B. E., Korbel, D., Hagens, K. et al. 2010. A role for IL- in protective immunity against Mycobacterium tuberculosis. Eur. J. Immunol. 40:396.
36. Winthrop, K. L., Chang, E., Yamashita, S., Iademarco, M. F. and LoBue, P. A. 2009. Nontuberculous mycobacteria infections and antitumor necrosis factor-alpha therapy. Emerg. Infect. Dis. 15:1556.
37. Jung, M. Y., Son, M. H., Kim, S. H., Cho, D. and Kim, T. S. 2011. IL-32gamma induced the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production. J. Immunol. 185:6848.
38. Nold, M. F., Nold-Petry, C. A., Pott, G. B. et al. 2008. Endogenous IL- controls cytokine and HIV-1 production. J. Immunol. 181:557.
39. Li, W., Liu, Y., Mukhtar, M. M. et al. 2008. Activation of interleukin- pro-inflammatory pathway in response to influenza A virus infection. Plos One 3:e1985.
40. Li, W., Yang, F., Liu, Y. et al. 2009. Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Eur. J. Immunol. 39:1.
41. Li, W., Sun, W., Liu, L. et al. 2010. IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J. Immunol. 185:5056.
42. Rasool, S. T., Tang, H., Wu, J. et al. 2008. Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication. Immunol. Lett. 117:161.
43. Netea, M. G., Azam, T., Ferwerda, G. et al. 2005. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc. Natl Acad. Sci. USA 102:16309.
44. Joosten, L. A., Netea, M. G., Kim, S. H. et al. 2006. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 103:3298.
45. Dinarello, C. A. and Kim, S.-H. 2006. IL-32, a novel cytokine with a possible role in disease. Ann. Rheum. Dis. 65 (Suppl. 3):61.
46. Calabrese, F., Baraldo, S., Bazzan, E. et al. 2008. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 178:894.
47. Chang, L. Y. and Crapo, J. D. 1990. Quantitative evaluation of minimal injuries. In Gil, J., ed., Models of Lung Disease: Microscopy and Structural Models, p. 597. Marcel Dekker, Inc, New York, NY.
48. Theus, S. A., Cave, M. D. and Eisenach, K. D. 2004. Activated THP-1 cells: an attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates. Infect. Immun. 72:1169.
49. Stockes, R. W. and Doxsee, D. 1999. The receptor-mediated uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages. Cell. Immunol. 197:1.
50. Riendeau, C. J. and Kornfeld, H. 2003. THP-1 cell apoptosis in response to Mycobacterial infection. Infect. Immun. 71:254.
51. Bai, X., Wilson, S. E., Chmura, K., Feldman, N. E. and Chan, E. D. 2004. Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis. Tuberculosis 84:375.
52. Wang, T., Lafuse, W. P. and Zwilling, B. S. 2001. NFkB and Sp1 elements are necessary for maximal transcription of Toll-like receptor 2 induced by Mycobacterium avium. J. Immunol. 167:6924.
53. Tse, H. M., Josephy, S. I., Chan, E. D., Fouts, D. and Cooper, A. M. 2002. Activation of the mitogen-activated protein kinase signaling pathway is instrumental in determining the ability of Mycobacterium avium to grow in murine macrophages. J. Immunol. 168:825.
54. Bermudez, L. E. and Young, L. S. 1994. Factors affecting invasion of HT-29 and HEp-2 epithelial cells by organisms of the Mycobacterium avium complex. Infect. Immun. 62:2021.
55. Bermudez, L. E. and Goodman, J. 1996. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect. Immun. 64:1400.
56. Reddy, V. M. and Kumar, B. 2000. Interaction of Mycobacterium avium complex with human respiratory epithelial cells. J. Infect. Dis. 181:1189.
57. García-Pérez, B. E., Mondragó n-Flores, R. and Luna-Herrera, J. 2003. Internalization of Mycobacterium tuberculosis by macropinocytosis in non-phagocytic cells. Microb. Pathog. 35:49.
58. Choi, J. D., Bae, S. Y., Hong, J. W. et al. 2008. Identification of the most active interleukin-32 isoform. Immunology 126:535.
59. Keane, J., Balcewicz-Sablinska, M. K., Remold, H. G. et al. 1997. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65:298.
60. Keane, J., Remold, H. G. and Kornfeld, H. 2000. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol. 15:2016.
61. Molloy, A., Laochumroonvorapong, P. and Kaplan, G. 1994. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. J. Exp. Med. 180:1499.
62. Lee, J., Hartman, M. and Kornfeld, H. 2009. Macrophage apoptosis in tuberculosis. Yonsei Med. J. 50:1.
63. Shioya, M., Nishida, A., Yagi, Y. et al. 2007. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin. Exp. Immunol. 149:480.
64. Smith, D., Hänsch, H., Bancroft, G. and Ehlers, S. 1997. T-cellindependent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-alpha and interferon-gamma. Immunology 92:413.
65. Ulrichs, T. and Kaufmann, S. H. 2006. New insights into the function of granulomas in human tuberculosis. J. Pathol. 208:261.
66. Winston, B. W., Chan, E. D. and Riches, D. W. H. 1997. Activation of p38mapk, MKK3, and MKK4 by tumor necrosis factor-alpha in mouse bone marrow-derived macrophages. J. Immunol. 159:4491.
67. Ko, N. Y., Mun, S. H., Lee, S. H. et al. 2011. Interleukin-32a production is regulated by MyD88-dependent and independent pathways in Il-1b-stimulated human alveolar epithelial cells. Immunobiology 216:32.
68. Zepp, J. A., Nold-Petry, C. A., Dinarello, C. A. and Nold, M. F. 2011. Protection from RNA and DNA viruses by IL-32. J. Immunol. 186:4110.
69. Bals, R. and Hiemstra, P. S. 2004. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J. 23:327.
70. Kato, A. and Schleimer, R. P. 2007. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr. Opin. Immunol. 19:711.
71. Fink, S. L. and Cookson, B. T. 2005. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73:1908.
72. Kang, J. W., Choi, S. C., Cho, M. C. et al. 2009. A proinflammatory cytokine interleukin-32beta promotes the production of an antiinflammatory cytokine interleukin-10. Immunology 128 (1 Suppl.): e532.
73. Choi, J., Bae, S., Hong, J. et al. 2010. Paradoxical effects of constitutive human IL-32{gamma} in transgenic mice during experimental colitis. Proc. Natl Acad. Sci. USA 107:21082.